Beta1-adrenergic agonist: Difference between revisions

Jump to navigation Jump to search
m (Protected "Beta1-adrenergic agonist": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
 
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
Line 1: Line 1:
{{CMG}}
{{CMG}}


{{EH}}
 


'''Beta<sub>1</sub>-adrenergic agonists''', also known as '''Beta<sub>1</sub>-adrenergic receptor agonists''', are a class of [[medication|drugs]] that bind selectively to the [[beta-1 adrenergic receptor]]. As a result, they act more selectively upon the [[heart]].
'''Beta<sub>1</sub>-adrenergic agonists''', also known as '''Beta<sub>1</sub>-adrenergic receptor agonists''', are a class of [[medication|drugs]] that bind selectively to the [[beta-1 adrenergic receptor]]. As a result, they act more selectively upon the [[heart]].

Revision as of 22:53, 8 August 2012

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Beta1-adrenergic agonists, also known as Beta1-adrenergic receptor agonists, are a class of drugs that bind selectively to the beta-1 adrenergic receptor. As a result, they act more selectively upon the heart.

Examples

Examples include denopamine,[1][2] dobutamine, and xamoterol.

References

  1. Sakuma T, Hida M, Nambu Y; et al. (2001). "Beta1-adrenergic agonist is a potent stimulator of alveolar fluid clearance in hyperoxic rat lungs". Jpn. J. Pharmacol. 85 (2): 161–6. PMID 11286398. Unknown parameter |month= ignored (help)
  2. Nishio R, Matsumori A, Shioi T; et al. (1998). "Denopamine, a beta1-adrenergic agonist, prolongs survival in a murine model of congestive heart failure induced by viral myocarditis: suppression of tumor necrosis factor-alpha production in the heart". J. Am. Coll. Cardiol. 32 (3): 808–15. PMID 9741531. Unknown parameter |month= ignored (help)


Template:Receptor agonists and antagonists


Template:WH Template:WS